Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Ordinary Share $0.00001 par value
-
Shares outstanding
-
50,588,235
-
Total 13F shares
-
44,821,941
-
Share change
-
-6,853,474
-
Total reported value
-
$1,159,982,320
-
Put/Call ratio
-
228%
-
Price per share
-
$25.89
-
Number of holders
-
103
-
Value change
-
-$103,049,474
-
Number of buys
-
58
-
Number of sells
-
32
Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) as of Q4 2019
As of 31 Dec 2019,
Theravance Biopharma, Inc. - Ordinary Share $0.00001 par value (TBPH) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
44,821,941 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, FMR LLC, Link Fund Solutions Ltd, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, NORGES BANK, STATE STREET CORP, Chescapmanager LLC, and Rock Springs Capital Management LP.
This page lists
103
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.